Award NoticeActiveSPE2D2-23-D-0002
Bupropion HCL ER
DEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY / DLA TROOP SUPPORTKey dates?
- Posted?
- Oct 12, 2022
- Response deadline?
- —
- Archive date?
- Oct 6, 2028
- Archive type?
- autocustom
Classification?
- Notice type?
- Award Notice
- Base type?
- Award Notice
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- 6505
NAICS?
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE LOGISTICS AGENCY
- Office?
- DLA TROOP SUPPORT
- Office code?
- —
- Organization type?
- OFFICE
- Office address?
- PHILADELPHIA, PA, 19111, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Hauppauge
- State?
- NY
- Zip?
- 11788
- Country?
- USA
Contacts?
- Ryan Ferryprimary
- Jason Wraysecondary
Summary?
DEPT OF DEFENSE has posted an open Award Notice: Bupropion HCL ER. It has a place of performance in Hauppauge. Reference number: SPE2D2-23-D-0002.
Award?
- Number?
- SPE2D2-23-D-0002
- Amount?
- $23,278,523.95
- Date?
- Oct 6, 2022
- Awardee?
- RADHA PHARMACEUTICALS INC NY 11788-3630 USA
- UEI?
- —
- Awardee address?
- —
Other notices in this solicitation?
- Award NoticeBupropion HCL ERSep 14, 2026LATEST
- Award NoticeBupropion HCL ERSep 14, 2023
- Award NoticeBupropion HCL ERJul 31, 2023
- Award NoticeBupropion HCL EROct 12, 2022
- Award NoticeBupropion HCL EROct 6, 2022
Similar open contracts
Metadata?
- Notice ID?
- 90ac1c4312ef48a2a43bb03a51991edc
- Full path?
- DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
- Office code?
- —
- Ingested?
- May 2, 2026
- Updated?
- Jul 28, 2026